Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Tortugas Neuroscience

tortugasneuro.com ↗

Clinical Phase 2

Profile checked Oct 10, 2026

Keywords: Tinnitus TRTL-729 TRTL-913

2Trials (company is sponsor)

Timeline

2026-09 Trial start Phase 1: A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729 source ↗
2026-09 Trial start Phase 2: A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B) source ↗

Upcoming milestones

2027-01 (ESTIMATED) · Phase 1 · A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729 · NCT07811063
2027-08 (ESTIMATED) · Phase 2 · A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B) · NCT07777549

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT07811063	A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729	Phase 1	Not yet recruiting	2026-09	2027-01 (estimated)
NCT07777549	A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B)	Phase 2	Not yet recruiting	2026-09	2027-08 (estimated)